All posts by imreal

Labor Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Harvard Partners Home Health, Inc. for Allegedly Failing to Reimburse Employees


Law Office of Blumenthal Nordrehaug Bhowmik De Blouw LLP

For more information about the class action lawsuit against Harvard Partners Home Health, Inc., call (800) 568-8020 to speak to an experienced California employment attorney today.

The Los Angeles employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action complaint alleging that Harvard Partners Home Health, Inc. violated the California Labor Code. The Harvard Partners Home Health, Inc. class action lawsuit, Case No. CVRI2203131, is currently pending in the Riverside County Superior Court of the State of California. A copy of the Complaint can be read here.

Harvard Partners Home Health, Inc. allegedly failed to reimburse employees for required business expenses. California Labor Code § 2802 expressly states that “an employer shall indemnify his or her employee for all necessary expenditures or losses incurred by the employee in direct consequence of the discharge of his or her duties…” During employment, Plaintiff and other California Class Members were allegedly required to use their personal cellular phones and personal home offices as a result of and in furtherance of their job duties.

Additionally, Defendant allegedly failed to provide employees with complete and accurate wage statements which showed, among other things, the correct gross and net wages earned. California Labor Code § 226 provides that every employer shall furnish each of his or her employees with an accurate itemized wage statement in writing showing, among other things, gross wages earned and all applicable hourly rates in effect during the pay period and the corresponding amount of time worked at each hourly rate.

For more information about the class action lawsuit against Harvard Partners Home Health, Inc., call (800) 568-8020 to speak to an experienced California employment attorney today.

Blumenthal Nordrehaug Bhowmik De Blouw LLP is an employment law firm with offices located in San Diego, San Francisco, Sacramento, Los Angeles, Riverside and Chicago that dedicates its practice to helping employees, investors and consumers fight back against unfair business practices, including violations of the California Labor Code and Fair Labor Standards Act. If you need help in collecting unpaid overtime wages, unpaid commissions, being wrongfully terminated from work, and other employment law claims, contact one of their attorneys today.

***THIS IS AN ATTORNEY ADVERTISEMENT***

Share article on social media or email:

NAIFA Announces New Employee and Executive Benefits Center to Aid Professionals Providing Business Resources


In a competitive job market, advisors’ business clients are focusing their attention on employee and executive benefits now more than ever. This is the perfect time for NAIFA to add EBC to its Specialty Centers roster.

The National Association of Insurance and Financial Advisors (NAIFA) announces the launch of the Employee and Executive Benefits Center (EBC), the newest of NAIFA’s Centers for Excellence, at NAIFA’s Apex sales summit. The EBC is a community of agents, firms, carriers, and vendors that offers top-notch resources, innovative research, access to industry thought leaders, and opportunities for collaboration in the benefits space.

Providing employee and executive benefits solutions is a crucial part of offering financial planning for business clients. In addition to traditional employee benefits programs, the EBC will look at how executive benefits play into retirement security, preparing to sell a business or to buy one, and much more. The Center will also investigate ways that the COVID-19 pandemic has changed the benefits landscape. Resources and experts accessible through the center will help advisors and firms navigate the marketplace, create efficiencies, and access information about the latest trends in the benefits universe.

LIMRA, the insurance and financial services industry’s leading research organization and identifier of market trends, has agreed to contribute featured content to the center. The center will cover a broad array of employee and executive benefits topics, including health care, dental services, wellness programs, supplemental employee benefits offerings, retirement planning, ERISA and COBRA plan documents, legal issues, and legislative and regulatory impacts.

Executive Director Carroll Golden, CLU, ChFC, LTCP, CASL, FLMI, CLTC, heads up the EBC. Golden is also the Executive Director of the NAIFA Limited and Extended Care Planning Center (LECP) and author of How Not to Tear Your Family Apart. She has worked closely with NAIFA Past President Cammie Scott, MSIE, ChHC, CLTC, REBC, RHU, SHRM-SCP, SPHR, to build out the center, shape its focus areas, and attract sponsors.

“In a competitive job market, advisors’ business clients are focusing their attention on employee and executive benefits now more than ever,” Golden said. “This is the perfect time for NAIFA to add EBC to its Specialty Centers roster. Employers are rethinking ways to attract and retain talent, incorporate meaningful benefits, and employ technology in applied and profitable ways. LIMRA, center sponsors, and NAIFA members specializing in employee benefits, will form a community to offer legislative insights, tools, research, and practical know-how to grow businesses.”

The EBC’s inaugural sponsors are:

  • New York Life
  • Principal
  • Guardian
  • MassMutual
  • Ameritas
  • LifeSecure
  • AGIS Network
  • Aetna Medical Solutions


EBC SPONSORS FEATURE AT APEX

EBC sponsors are strongly represented among the speakers and featured programming at NAIFA’s Apex sales summit at the Arizona Biltmore in Phoenix. The Apex Pre-Conference Experience events “Advocacy Accelerator Course for Women” and “Advocacy Accelerator Course for Hispanic Advisors” featured New York Life Partner Evelyn Gellar, LUTCF, RICP, CLTC, FSCP, who is also a member of NAIFA’s Board of Trustees and Diversity, Equity, and Inclusion Council. Also during the pre-conference, Golden was a co-presenter of a Long Term Care Workshop sponsored by NAIFA’s LECP.

Ameritas Vice President Advanced Markets & Competition and Case Design Andrew Rinn, JD, CFP, CLU, ChFC, offered his presentation, “Calling All Advisors! It’s Time to Focus on You,” during the August 17 networking break in the Apex exhibit hall. Aetna’s National Sales Director of Ancillary Products Jamie Sarno will participate in a panel discussion during the August 18 Learning Lab, “TLC Planning in a 5G World.”

Guardian is sponsoring Apex keynote speaker Caleb Guilliams, the Founder and CEO of BetterWealth, introduced by Ed Youmell, CLU, FLMI, Field Vice President, Head of Life & DI Sales at Guardian. MassMutual is sponsoring Apex keynote Speaker Morris Morrison, introduced by Joesph Sparacio, Head of Field Management at MassMutual. Additionally, Principal, Ameritas, and LifeSecure will have booths in the Apex exhibit hall.

ABOUT NAIFA: The National Association of Insurance and Financial Advisors is the preeminent membership association for the multigenerational community of financial professionals in the United States. NAIFA members subscribe to a strong Code of Ethics and represent a full spectrum of financial services practice specialties. They work with families and businesses to help Americans improve financial literacy and achieve financial security. NAIFA provides producers a national community for advocacy, education and networking along with awards, publications and leadership opportunities to allow NAIFA members to differentiate themselves in the marketplace. NAIFA has 53 state and territorial chapters and 35 large metropolitan local chapters. NAIFA members in every congressional district advocate on behalf of producers and consumers at the state, interstate and federal levels.

Share article on social media or email:

Heritage Place Assisted Living & Memory Care named Burleson’s favorite


“Being recognized by the community shows that Heritage Place Assisted Living & Memory Care provides its residents with the highest quality of service and care,” Sagora Senior Living Corporate Director of Operations Christal Hoffman said.

Heritage Place Assisted Living & Memory Care, located in Burleson, TX has been named a Local Favorite by Local Life magazine.

The magazine’s readers voted the Sagora Senior Living community as their favorite community for local senior care in the Burleson, Crowley and Joshua areas. The vote was part of the magazine’s 2022 Local Love awards, and the magazine is set to feature the community in its health-themed September issue.

“Being recognized by the community shows that Heritage Place Assisted Living & Memory Care provides its residents with the highest quality of service and care,” Sagora Senior Living Corporate Director of Operations Christal Hoffman said. “Winning this award demonstrates that the community extends a tremendous level of service to families of its residents.”

Heritage Place Assisted Living & Memory Care is located on Old Highway 1187 in Burleson. It offers individualized, adaptive care plans for both Assisted Living & Memory Care residents. Programs are focused on providing residents with a sense of peace, comfort and dignity while allowing them to remain active for as long as possible.

ABOUT SAGORA SENIOR LIVING

Sagora Senior Living is among the nation’s top-50 senior housing providers and abides by a Resident-First philosophy. The company operates more than 50 communities in 11 states, with Cottages, Independent Living, Assisted Living and Memory Care living options. For additional information, please visit Sagora.com.

Share article on social media or email:

Medical Transcribers Must Eschew AI to Save Lives, Says Alphabet Transcription Services Founder


Herts-based Alphabet Transcription Specialists are bucking the trend of AI-driven transcription processes to ensure life-saving accuracy for their clients in the healthcare industry. With 25 years in the transcription industry, serving both pharmaceutical and medical clients, Alphabet founder Denise Elsdon sounds the alarm against transcription services that have switched to AI-generated transcription, particularly in the healthcare sector. She states, “What many healthcare providers don’t realize is how bad the AI software is at producing accurate transcripts. Unfortunately, lots of AI software companies are offering this service and transcription companies are jumping on the bandwagon. And, when you pair these inaccuracies with people whose native language isn’t English, it’s a minefield.”

Research bears out her insights. According to this article, AI systems rely on training data sets to “learn” how to transcribe conversations. If that data comes with a bias towards a particular accent, the resulting transcription will be less accurate. The authors advise healthcare providers, “If the data collected is biased, that is, it targets a particular race, a particular gender, a specific age group, then the resulting model will be biased.”

The pharmaceutical industry is changing daily and new drugs and regulations are constantly being introduced. Vast knowledge and expertise are required to understand this specialized industry. New data needs to be introduced to the AI regularly and, again, not be biased between the different races, genders, and accents. And for AI to maintain its integrity, this data would need to be brought in from different regions throughout the UK, allowing for all dialects to be learned and maintained.

Even more telling is a TechCrunch article that reports the progress speech recognition company Speechmatics has made in transcribing accented speech. As writer Devin Coldewey points out, Speechmatics’ latest AI-powered transcription model achieved only an 82.8% accuracy rate when analyzing Black people’s voices. That’s simply not acceptable when lives are at stake, as in pharmaceutical — and even legal — transcriptions, according to Denise. “Because we deal with a lot of pharmaceutical clients, we’ve found that drug names and diseases often aren’t spelt correctly in AI-generated transcriptions. They even miss whether a drug is branded or generic. And some of our clients request some parts of their transcriptions verbatim, which is even more of a challenge for AI transcription models,” she adds.

That 82.8% rate applies only to African-American accents. Even a leading-edge model like Speechmatics, the TechCrunch article admitted, could only make “small but significant improvements” for Southern African, Scottish, Filipino, and Indian accents. With the UK’s National Health Service (NHS) reporting that nearly 15% of NHS staff hail from nations other than the UK, this should sound the alarm among healthcare providers considering AI transcriptions, Denise points out.

These are not the only studies showing inaccuracy in artificial intelligence transcription. A 2010 study found error rates of just over 23% when using AI for transcription. It also goes on to state that AI just cannot keep up with spontaneous human speech and utterings and transcribe them with certainty. This margin of error is just too large when dealing with human lives.

With different dialects and jargon being used, not only in different countries within the United Kingdom but also in different regions within the individual countries in the UK, it’s easy for the AI to misinterpret comments a human would easily understand. The acronyms alone vary within the pharmaceutical industry, and that is not something that AI can currently determine.

This is best summed up by Denise Elsdon with her perspective on the dangers of using AI translation software for pharmaceutical applications. She says, “All in all, there is nothing more accurate than the human ear and thorough research. These factors are all lacking in speech recognition software. For that reason, Alphabet Transcription Specialists will continue to employ expert human transcriptionists to deliver pinpoint accuracy to our pharmaceutical clients.”

Alphabet Transcription Specialists is a UK-based transcription company with over 25 years of experience providing accurate transcriptions in diverse fields, including pharmaceutical, medical, and legal. Its all-native English-speaking staff understand the nuances of the English language, including varied accents, dialects, colloquialisms, and acronyms. They never outsource work due to the nuances associated with these varied dialects. With broad expertise in the pharmaceutical and medical industries’ terminology, Alphabet has become the transcription company of choice for UK firms for whom accuracy is paramount.

Share article on social media or email:

Sun Mar Healthcare Employs Over 100 New Graduates of Free EduTrack CNA Program


News Image

Recognizing that dedicated, quality staff makes all the difference in healthcare, our goal is to help train caring, skilled and compassionate people that want to grow within our organization to take care of our residents.

Sun Mar Healthcare’s affiliated nursing school, EduTrack School of Nursing, is celebrating the largest graduating class ever of its free CNA training program. The 82 graduates joined another 30 recent graduates in receiving a guaranteed offer of employment at any of Sun Mar’s 42 healthcare facilities.

As one of the only healthcare companies in California with an independently owned nursing school, Sun Mar Healthcare is taking impressive actions to solve California’s nursing shortage. Its EduTrack program is accredited by statewide healthcare organizations, and Sun Mar receives no reimbursement from the government for offering its CNA training program for free.

“Recognizing that dedicated, quality staff makes all the difference in healthcare, our goal is to help train caring, skilled and compassionate people that want to grow within our organization to take care of our residents,” said Nicole Vandecamp, director of EduTrack. “This is just one step for what should be a fulfilling health career for these students.”

Though Sun Mar’s EduTrack program aims to solve healthcare staffing shortages in its facilities and community, the program is also intended to help individuals who are impoverished or lack a formal education create fulfilling lives and careers. By providing free training and job placement, Sun Mar is helping students from a variety of backgrounds make valuable changes in their lives.

“What we’ve learned here is not just how to take care of someone, but the skills to know how to enrich the quality of life for those that are in our care,” said Roger Morales, a recent EduTrack graduate and valedictorian. “I take with that a great responsibility on what that relationship entails to them first and foremost.”

In just a few weeks, Edutrack School of Nursing will have expanded from two affiliated locations to nine, each offering day and evening courses in Santa Ana, San Gabriel, North Hollywood, Los Angeles, Riverside, Brea, San Diego, Pomona and La Mirada. In two years, Sun Mar Healthcare plans to expand EduTrack into a full-scale nursing school, including CNA, LVN and RN programs. Sun Mar Healthcare has also recently acquired 10 new nursing facilities and looks forward to assisting these new communities through its Edutrack School of Nursing graduates.

About Sun Mar Healthcare

Sun Mar Healthcare is a long-term care advisory and services organization providing operational support for 42 skilled nursing facilities and one assisted living facility. For over 35 years, Sun Mar has provided a broad array of services for healthcare facilities, including clinical system advisory and training, back-office accounting, legal and other services for owners and/or operators of long-term healthcare facilities.

Share article on social media or email:

EchoNous Alliance with Samsung Aims to Put AI-guided Ultrasound in More Doctors’ Hands


Thanks to a new Samsung/EchoNous alliance, medical personnel can now run the Kosmos Platform using Samsung’s Galaxy Tab Active Pro Models 12.0 and higher

Our overarching goal is to democratize the use of ultrasound in bedside medicine. When we can utilize existing technology for that purpose, we make these tools that much more accessible.

EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, today announced an alliance with electronics giant Samsung, makers of the Galaxy line of mobile tablets. Kosmos, EchoNous’s powerful AI-guided handheld ultrasound tool, will now be able to run on off-the-shelf Galaxy Tab Active Pro tablets; models 12.0 and higher.

Made possible through the EchoNous/Samsung alliance, this new compatibility will lower the overall price point of the Kosmos platform, which already costs tens of thousands of dollars less than the cart-based models that Kosmos has been benchmarked against. This compatibility is only possible because of the Active Pro tablet’s exceptional speed, power, and battery life.

“Even for the largest medical providers in the world, every dollar saved is one that can be spent saving another life, and this alliance with Samsung makes it possible for our platform to run on a more economical, off-the-shelf tablet,” explained Kevin Goodwin, CEO of EchoNous. “Doctors can now use a tablet that they may already be familiar with and it will still run our platform flawlessly because of its inherent power.”

Until now, the Kosmos platform has only been operable with Kosmos Bridge, EchoNous’s custom-designed display. Kosmos Bridge was designed specifically for medical use and features minimal surface area and system buttons that are protected in sealed silicone rubber. While the product will remain on the market, compatibility with Galaxy Tab Active Pro models creates more options for medical practitioners and hospital procurement staff.

Kosmos is the only handheld ultra-mobile tool that offers diagnostic-grade imaging with continuous-wave Doppler capability. Kosmos’ AI-driven system enables automated assessment of systolic heart function at bedside and is the only device in its category to provide diagnostic-quality scans while also meeting HIPAA requirements for data collection, storage, and transmission. Kosmos is rapidly emerging as a tool of choice for cardiologists and critical care medicine.

“Our overarching goal is to democratize the use of ultrasound in bedside medicine. When we can utilize existing technology for that purpose, we make these tools that much more accessible,” added Goodwin. “And Samsung customers – even if they’re not medical personnel or never need an ultrasound – can feel good knowing that the devices they depend on for work and play are also helping diagnose patients and save lives around the world.”

About EchoNous

Founded in 2016, EchoNous develops industry-leading, intelligent POCUS tools that help medical professionals solve common everyday problems in healthcare. Its flagship device, Kosmos, offers diagnostic-quality heart, lung, and abdominal scans in a handheld tool. The product offers ultrasound, ECG, color pulsed-wave and continuous-wave Doppler capabilities, acts as a digital stethoscope, and provides AI-guided cardiac scanning – an industry first in a single device. Learn more at http://www.echonous.com.

Share article on social media or email:

TwelveStone Health Partners Ranks No. 1,827 on the 2022 Inc. 5000 Annual List


News Image

Today, Inc. revealed TwelveStone Health Partners is No. 1,827 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the economy’s most dynamic segment—its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“We are honored to receive this for a third year,” says Dave Carter, chief revenue officer, TwelveStone Health Partners. “Our ranking reflects the diligent work done by our business development team in expanding our foot-print across the southeast.”

The companies on the 2022 Inc. 5000 have not only been successful, but have also demonstrated resilience amid supply chain woes, labor shortages, and the ongoing impact of Covid-19. Among the top 500, the average median three-year revenue growth rate soared to 2,144 percent. Together, those companies added more than 68,394 jobs over the past three years.

“Our rapid expansion and success during the pandemic are a testament to the incredible service we deliver to every patient struggling with a long-term chronic condition,” said Shane Reeves, chief executive officer, TwelveStone Health Partners. “We are thrilled to receive this award for the third straight year.”

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are featured in the September issue of Inc. magazine, which will be available on August 23.

“The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated,” says Scott Omelianuk, editor-in-chief of Inc. “Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today.”

About TwelveStone Partners

TwelveStone Health Partners incorporates the objective of glorifying God into its mission by delivering a higher level of service to partners and patients. As an organization, TwelveStone supports the transition from acute to post-acute care environments and the transition from sickness to health. This is the third evolution in the company’s history, beginning in 1980 when Richard Reeves and Ronald Powell created a single retail pharmacy location then called Reeves Powell Saveway Drug Store. In 1994 Shane Reeves and Rick Sain launched Reeves-Sain, and over 20 years grew the organization to include seven companies. In 2015 Reeves Sain Drug Store, Inc., a retail pharmacy, and its specialty pharmacy, EntrustRx were sold to Fred’s, Inc. In 2016 Shane Reeves launched TwelveStone Health Partners, intending to continue pursuing the highest professional, business, and community goals set forth by its founders. For more information, visit http://www.12stonehealth.com.

More about Inc. and the Inc. 5000

Methodology

Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2018 to 2021. To qualify, companies must have been founded and generating revenue by March 31, 2018. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2021. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2018 is $100,000; the minimum for 2021 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places. The top 500 companies on the Inc. 5000 are featured in Inc. magazine’s September issue. The entire Inc. 5000 can be found at http://www.inc.com/inc5000.

About Inc.

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference & Gala is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference & Gala, visit http://conference.inc.com/.

Share article on social media or email:

InHome Therapy Grows its Reach Through Acquisition of Advanced Healthcare Services


InHome Therapy, the company dedicated to delivering caring physical, occupational, and speech therapy solutions in the comfort of patients’ residences, is celebrating the acquisition of Advanced Healthcare Services. The deal closed in early July and marks a major step forward in InHome Therapy’s continued growth throughout Florida.

Advanced Healthcare Services was started in West Palm Beach in 2010 by Jeremy Gabler. In the 12 years since the company’s inception, it has grown an enviable list of accounts and a strong team of quality therapists. The new acquisition means Advanced Healthcare Services’ therapists and administrative team are now operating under the InHome Therapy name.

“The primary reason for this deal is that it allows us to continue to expand throughout Florida and be the dominant in-home therapy provider. We can service more home health agencies and more patients in that area by increasing our talented community of therapists,” explained Richard Anglin, InHome Therapy’s Corporate Development Officer.

Advanced Healthcare Services also offered physical, occupational and speech therapy services to patients in their home, so “the transition has been easy,” Anglin said. “We already have a significant presence in that area and a very talented operations team there to help.”

Gabler sold the company to InHome Therapy so he can focus on his private care and outpatient therapy companies, but will continue to work alongside the business. “I absolutely love the way they are doing it, having these services all over. I would have loved to operate like that, had I had the resources.” Gabler added. “This acquisition is going to aid InHome Therapy. They’ll deepen relationships through these new partnerships and be the first call and ones to capture all of the business.”

About InHome Therapy

InHome Therapy leverages its unmatched systems, processes, and tools to unlock a new approach for delivering sustainable and measurable results to home therapy patient care, ensuring that patients, agencies, and therapists rise together. Today InHome Therapy employs hundreds of therapists and has completed over 2 million patient visits in key locations across the country, utilizing powerful and easy-to-use tools and training that allow therapists to continuously deliver optimal care. For more information, visit http://www.inhometherapy.com.

Share article on social media or email:

SpIntellx and iCura Diagnostics Partner to Expand Access to Advanced Spatial Analytics and Explainable AI Products for Pathology and Oncology Research


SpIntellx and iCura Diagnostics Announce Partnership

Together with iCura, we will be able to improve prediction accuracies and drive personalized therapeutic options for selecting optimal therapeutics based on insights into spatial tumor biology of individual patients and their potential outcomes.

SpIntellx, Inc., a leader in spatially intelligent biology and iCura Diagnostics, a leading contract research organization focused on capitalizing multiomic data to accelerate end-to-end clinical workflow solutions and biomarker discovery, have announced a partnership to transform precision oncology through unlocking the power of genomic, proteomics, and transcriptomic data using advanced spatial analytics.

This new partnership combines SpIntellx’s software as a service (SaaS) based solutions for precision pathology applications harnessing unbiased spatial analytics and explainable AI with iCura Diagnostics’ expertise as a technical CRO propelling the pace of immunotherapy and targeted therapy development. iCura’s multiplex assay development and genomic and transcriptomic capabilities focused on unravelling novel spatial signatures in high-plex assays helps predict responses to immunotherapy and boost confidence in treatment recommendations. Through this strategic alliance, iCura Diagnostics and SpIntellx will deliver advanced spatial analytics and explainable AI-powered decisions at scale across the drug development continuum driving integration of multimodal data, optimizing clinical workflow, accelerating biomarker discovery, and empowering personalized care. The companies plan to launch a suite of solutions which combine genomic, proteomic, transcriptomic and clinical data to explore the complex spatial heterogeneity in the tumor microenvironment (TME). Their novel approaches include unlocking key spatial interactions through the discovery of microdomains in the TME which contribute to disease progression and proliferation.

“This partnership comes at a tipping point in the spatial biology market with emerging evidence underscoring the need for precision convergence with multimodal data in order to reveal the hidden circuitries in the tumor microenvironment, predict more accurately responses to immunotherapy and inform treatment decisions,” said B. Dusty Majumdar, PhD, CEO of SpIntellx. “Together with iCura, we will be able to improve prediction accuracies and drive personalized therapeutic options for selecting optimal therapeutics based on insights into spatial tumor biology of individual patients and their potential outcomes.”

Buer Song, MD. PhD, CEO of iCura Diagnostics stated, “We are delighted to partner with SpIntellx to take our precision convergence-based solutions to the next level to empower biopharma and create better outcomes for patients. Our combined expertise in multiplexing (or multiplex spatial imaging), explainable AI and unbiased spatial analytics will radically transform spatial biology and generate hitherto unprecedented spatial insights to radically improve our approach to immunotherapy in the future.”

About SpIntellx

SpIntellx, Inc., is the precision pathology company based in Pittsburgh, PA that applies its proprietary unbiased spatial analytics and explainable AI to transform computational and systems pathology to precision pathology and guide clinicians and researchers with powerful tools so they can See More, Know More, and Power Precision Pathology.

SpIntellx offers software as a service (SaaS) for precision pathology applications harnessing unbiased spatial analytics and explainable AI including: accelerated drug discovery for identifying novel targets, biomarkers and “invisible” cell types; optimized clinical trials for precision patient stratification; advanced companion diagnostics for radically improving prediction accuracies through deep insights into biological mechanisms of action; and personalized therapeutic options for selecting optimal therapeutics based on insights into probable patient outcomes.

For more information on SpIntellx, please visit: http://www.spintellx.com

About iCura Diagnostics

iCura Diagnostics, located in Great Valley Industrial Park, provides diagnostic testing and services for the pharmaceutical industry, academic research center, and partner CRO and laboratories. iCura has a CLIA/CAP accredited laboratory which has Pennsylvania Department of Health issued laboratory permit for clinical diagnostic tests as well. The company has a highly experienced team composed of board-certified pathologists and PhD level scientists, with active medical licenses and other professional certifications.

iCura is recognized as a leading CRO providing Whole Slide Imaging, multiplex IHC/IF, Image Analysis, Circulating Tumor Cells, and other high-end pathology testing in a CLIA environment. More recently, iCura has focused on exploring the relationship between biomarkers expressed in the TME as well as combining the data from proteomics and genomics to gain deeper understanding of both spatial and temporal heterogeneity within the tumor.

The details of the service items could be found on their website, http://www.icuradx.com.

Share article on social media or email:

Sightmd Physicians Recognized On Newsweek’s List Of Best Ophthalmologists For 2022


News Image

“I am humbled and honored to be recognized by my peers as one of America’s Top Ophthalmologists. It is such a privilege to serve patients every day along with the support of my dedicated team. I love my job and look forward to providing the best care to all my patients.” said Dr. James Gordon.

Dr Jeffrey Martin and Dr James Gordon have been included on this year’s list of “America’s Best Ophthalmologists,” published by Newsweek, where they rank among 175 selected physicians. This prestigious award is presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on July 20th, 2022 and can currently be viewed on the Newsweek website.

After surveying more than 10,000 professionals from the nation’s eye care field, the results are in for this year’s top 175 ophthalmologists. Dr. James Gordon was ranked 2nd in New York and 21st in the nation, and Dr. Jeffrey Martin was ranked 6th in New York and 36th in the nation.

James R. Gordon, MD, is a board-certified ophthalmologist and oculofacial surgeon with over 20 years of experience. He has particular expertise in the handling of challenging and complex cases. Dr. Gordon has published numerous papers and given extensive lectures on ocular disease and eyelids as well as facial cosmetic procedures which include innovative techniques for fillers and injectables.

“I am humbled and honored to be recognized by my peers as one of America’s Top Ophthalmologists. It is such a privilege to serve patients every day along with the support of my dedicated team. I love my job and look forward to providing the best care to all my patients,” said Dr. James Gordon.

Jeffrey Martin, MD, is the co-founder and president of SightMD. His father founded the practice in 1962, and Dr. Martin is proud to have helped it become the leading eye care organization that it is today with more top doctors than any other practice in New York. Dr. Martin is a board-certified ophthalmologist who specializes in cataract and laser vision correction (LASIK) eye surgery in Smithtown.

“I am honored to be included on this list with some of the finest ophthalmologists in the country. This recognition belongs to the entire team at SightMD. Everyone works so hard to provide the best in eye care to our patients with incredible availability 7 days a week,” said Dr. Jeffrey Martin.

More than 5,500 health care professionals participated in the national survey—implemented by Statista—which asked them to recommend the best ophthalmologist in their state and in the US. Additionally, participants were asked to rank certain specifics that influence the quality of eye doctors, which include the sophistication of technical equipment and continuity of care as well as overall quality of care. The recommendations and quality score were analyzed to determine the 2022 list of “America’s Best Ophthalmologists.”

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group that offers patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

Share article on social media or email: